5Darrell C. Keenneth A. Recent advanccs in flow cytomelry: application to the diagnosis of hemaloligic malignancy [J]. Blood,1997,90(8) :2863-2892.
6Kern W, Haferlach C, Haferlach T, et al. Monitoring of minimal residual disease in acute myeloid leukemia[J]. Cancer, 2008,112(1) :4-16.
7Carow C E. Levenstein M, Kaufmann S H, et al. Expression of the hematopoietic growth factor receptor FLT3 (STK1/STK2) in human leulemias[J]. Blood,1996,87(3):1089-1096.
8Ikeda H, Lethe B, Lehman F, et al. Characterization of an antigen thai is recognized on a melanoma showing partial HLA loss CTL expressing an NK inhibitory receptor[J]. Immunity, 1997,11(6):199-208.
9Matsushita M, Ikeda H, Kizaki M, et al. Quantitative monitoring of the PRAME gene for the detection ot minimal residual disease in leukemia[J]. Br J Haematol,2001,3(4): 916-926.
10Spanaki A, Perdikogianni C, Linardakis E, et al. Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia[J]. Leuk Res,2007,31(5):639-642.
